Both in Pharmaceuticals
Monopar Therapeutics vs Evolus
Over the past year MNPR returned +5.4% and EOLS returned +30.1%; their daily moves had a correlation of 0.17.
MNPR +5.4% EOLS +30.1%Growth of $1, one year, split-adjusted
| Metric | MNPR | EOLS |
|---|---|---|
| Price | $80.00 | $7.99 |
| Market cap | $537.0M | $527.7M |
| Today | −4.44% | +0.38% |
| 1 month | −28.5% | −10.0% |
| 6 months | +50.1% | +102.8% |
| Year to date | +22.5% | +20.2% |
| 1 year | +4.4% | +33.4% |
| Revenue growth (YoY) | — | +21.2% |
| Gross margin | — | 68.0% |
| Net margin | — | −9.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.7× |
| Net cash | $134.3M | -$141.9M |
| Dividend yield | — | — |
| Volatility (60d) | 58.8% | 60.7% |
| Short % of float | 17.4% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).